- Company Directors - L
- Loughlin James J
Insider Trading History of Loughlin James J
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Loughlin James J since 2005.
The trader's CIK number is 1276550.
At the time of the last reporting, Loughlin James J was the Director of Celgene Corp /de/. (stock ticker symbol CELG).
Also see all insider trading activities at Celgene Corp /de/.
Note that in the past
LOUGHLIN JAMES J also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Edge Therapeutics, Inc. (EDGE) by Loughlin James J
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | EDGE | 0 | $0 | 0 | $0 | 10,000 | $0 |
| 2017 | EDGE | 3,000 | $27,720 | 0 | $0 | 0 | $0 |
| 2016 | EDGE | 3,000 | $22,875 | 0 | $0 | 0 | $0 |
| 2015 | EDGE | 7,000 | $77,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Datascope Corp (DSCP) by Loughlin James J
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2005 | DSCP | 1,000 | $29,800 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Alfacell Corp (ACEL) by Loughlin James J
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2006 | ACEL | 7,500 | $15,262 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Celgene Corp /de/ (CELG) by Loughlin James J
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | CELG | 0 | $0 | 23,466 | $2,048,323 | 27,891 | $554,245 |
| 2018 | CELG | 0 | $0 | 27,000 | $2,252,632 | 40,075 | $1,084,192 |
| 2017 | CELG | 0 | $0 | 27,750 | $3,618,045 | 29,192 | $812,242 |
| 2016 | CELG | 0 | $0 | 27,500 | $3,137,750 | 30,634 | $718,162 |
| 2015 | CELG | 0 | $0 | 0 | $0 | 4,867 | $0 |
| 2014 | CELG | 0 | $0 | 20,000 | $1,825,000 | 22,066 | $573,000 |
| 2013 | CELG | 0 | $0 | 0 | $0 | 1,718 | $0 |
| 2012 | CELG | 600 | $36,174 | 0 | $0 | 1,370 | $0 |
| 2011 | CELG | 0 | $0 | 0 | $0 | 1,370 | $0 |
| 2010 | CELG | 0 | $0 | 0 | $0 | 685 | $0 |
| 2009 | CELG | 600 | $23,742 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Inspiremd, Inc. (NSPR) by Loughlin James J
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | NSPR | 50,000 | $29,500 | 0 | $0 | 0 | $0 |
| 2013 | NSPR | 15,000 | $30,000 | 0 | $0 | 0 | $0 |
Insider trading activities at 5 companies by Loughlin James J:
1. Edge Therapeutics, Inc. (EDGE)
2. Datascope Corp (DSCP)
3. Alfacell Corp (ACEL)
4. Celgene Corp /de/ (CELG)
5. Inspiremd, Inc. (NSPR)
Table 1. Insider trading of Edge Therapeutics, Inc. (EDGE) by Loughlin James J
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-03-15 | EDGE | Option Ex | 10,000 | .00 | 0 |
| 2017-03-06 | EDGE | Buy | 3,000 | 9.24 | 27,720 |
| 2016-03-11 | EDGE | Buy | 3,000 | 7.62 | 22,875 |
| 2015-10-06 | EDGE | Buy | 7,000 | 11.00 | 77,000 |
Table 2. Insider trading of Datascope Corp (DSCP) by Loughlin James J
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2005-05-19 | DSCP | Buy | 1,000 | 29.80 | 29,800 |
Table 3. Insider trading of Alfacell Corp (ACEL) by Loughlin James J
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2006-07-25 | ACEL | Buy | 7,500 | 2.04 | 15,262 |
Table 4. Insider trading of Celgene Corp /de/ (CELG) by Loughlin James J
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-06-13 | CELG | Option Ex | 484 | .00 | 0 |
| 2019-06-14 | CELG | Option Ex | 300 | .00 | 0 |
| 2019-06-15 | CELG | Option Ex | 2,441 | .00 | 0 |
| 2019-02-07 | CELG | Option Ex | 24,666 | 22.47 | 554,245 |
| 2019-02-07 | CELG | Sale | 23,466 | 87.29 | 2,048,323 |
| 2018-06-17 | CELG | Option Ex | 334 | .00 | 0 |
| 2018-06-14 | CELG | Option Ex | 300 | .00 | 0 |
| 2018-06-15 | CELG | Option Ex | 2,441 | .00 | 0 |
| 2018-06-04 | CELG | Option Ex | 27,750 | 30.01 | 832,777 |
| 2018-06-04 | CELG | Sale | 17,750 | 78.96 | 1,401,540 |
| 2018-03-12 | CELG | Sale | 9,250 | 92.01 | 851,092 |
| 2018-03-12 | CELG | Option Ex | 9,250 | 27.18 | 251,415 |
| 2017-07-01 | CELG | Option Ex | 734 | .00 | 0 |
| 2017-06-26 | CELG | Option Ex | 18,500 | 29.43 | 544,362 |
| 2017-06-26 | CELG | Sale | 18,500 | 133.57 | 2,471,045 |
| 2017-06-17 | CELG | Option Ex | 333 | .00 | 0 |
| 2017-06-15 | CELG | Option Ex | 375 | .00 | 0 |
| 2017-05-01 | CELG | Option Ex | 9,250 | 28.96 | 267,880 |
| 2017-05-01 | CELG | Sale | 9,250 | 124.00 | 1,147,000 |
| 2016-08-23 | CELG | Sale | 27,500 | 114.10 | 3,137,750 |
| 2016-08-23 | CELG | Option Ex | 27,500 | 26.11 | 718,162 |
| 2016-07-01 | CELG | Option Ex | 733 | .00 | 0 |
| 2016-06-17 | CELG | Option Ex | 333 | .00 | 0 |
| 2016-06-12 | CELG | Option Ex | 2,068 | .00 | 0 |
| 2015-07-01 | CELG | Option Ex | 733 | .00 | 0 |
| 2015-06-13 | CELG | Option Ex | 2,068 | .00 | 0 |
| 2015-06-12 | CELG | Option Ex | 2,066 | .00 | 0 |
| 2014-08-22 | CELG | Option Ex | 20,000 | 28.65 | 573,000 |
| 2014-08-22 | CELG | Sale | 20,000 | 91.25 | 1,825,000 |
| 2014-06-12 | CELG | Option Ex | 1,033 | .00 | 0 |
| 2014-06-13 | CELG | Option Ex | 1,033 | .00 | 0 |
| 2013-06-13 | CELG | Option Ex | 1,033 | .00 | 0 |
| 2013-06-16 | CELG | Option Ex | 685 | .00 | 0 |
| 2012-06-22 | CELG | Buy | 600 | 60.29 | 36,174 |
| 2012-06-17 | CELG | Option Ex | 685 | .00 | 0 |
| 2012-06-16 | CELG | Option Ex | 685 | .00 | 0 |
| 2011-06-16 | CELG | Option Ex | 685 | .00 | 0 |
| 2011-06-17 | CELG | Option Ex | 685 | .00 | 0 |
| 2010-06-17 | CELG | Option Ex | 685 | .00 | 0 |
| 2009-05-06 | CELG | Buy | 600 | 39.57 | 23,742 |
Table 5. Insider trading of Inspiremd, Inc. (NSPR) by Loughlin James J
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-03-21 | NSPR | Buy | 50,000 | .59 | 29,500 |
| 2013-04-16 | NSPR | Buy | 15,000 | 2.00 | 30,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Loughlin James J
(Director of Celgene Corp /de/ at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.